Gladstone NOW: The Campaign Join Us on the Journey✕
211 - 225 of 339 Results Clear All
San Francisco Chronicle—Gladstone Senior Investigators Melanie Ott and Warner Greene explain the potential risks and benefits of steroid treatments for COVID-19 patients.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab Ott Lab
San Francisco Chronicle—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, comments on the recent report that dexamethasone, a common anti-inflammatory drug, reduces the death rate of severely ill COVID-19 patients by one third.
Gladstone Experts COVID-19 Virology Ott Lab
ImmunoFrontiers—Senior Investigator Katerina Akassoglou, PhD, describes her lab's recent discovery of the genetic mechanisms that drive brain inflammation in neurodegenerative diseases.
Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.
Gladstone Experts COVID-19 Virology Ott Lab
In this episode of the Newton Series, Katie Pollard shares how big data allows for deep exploration of the human microbiome.
Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Microbiome
San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.
Gladstone Experts COVID-19 Virology Greene Lab
Deep Background with Noah Feldman—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, shares the results of his lab's evaluation of currently available antibody tests for SARS-CoV-2 infection.
Gladstone Experts COVID-19 Genomic Immunology Marson Lab
SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.
Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab
Get a deeper look at the most promising COVID-19 projects at Gladstone.
Gladstone Experts COVID-19
San Francisco Chronicle—Senior Investigator Warner Greene comments on how people can reduce risks when resuming get-togethers with friends or family.
Gladstone Experts COVID-19 Greene Lab
In this edition of the Newton Webinar Series, Jeanne Paz shared her lab’s unique approach to understanding the mechanisms of epilepsy and how it could lead to potential treatments.
Gladstone Experts Epilepsy Neurological Disease Paz Lab
When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.
Gladstone Experts COVID-19 Virology Greene Lab
The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.
Gladstone Experts COVID-19 Virology Ott Lab
Inverse—A new study shows that speaking loudly can release droplets that contain coronavirus and have the potential to remain airborne for up to 14 minutes. Senior Investigator Warner Greene explains that any amount of the virus has the potential to cause infection.
Gladstone Experts COVID-19 Virology Greene Lab
